Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration

被引:93
作者
Kruer, Michael C. [2 ,3 ]
Hiken, Mark [4 ]
Gregory, Allison [1 ]
Malandrini, Alessandro [5 ]
Clark, David [4 ]
Hogarth, Penny [1 ,6 ]
Grafe, Marjorie [4 ]
Hayflick, Susan J. [1 ,6 ,7 ]
Woltjer, Randall L. [4 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Div Dev Paediat, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Div Paediat Neurol, Child Dev & Rehabil Ctr, Portland, OR 97239 USA
[4] Oregon Hlth & Sci Univ, Sect Neuropathol, Dept Pathol, Portland, OR 97239 USA
[5] Univ Siena, Unit Neurometab Dis, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy
[6] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA
[7] Oregon Hlth & Sci Univ, Dept Paediat, Portland, OR 97239 USA
基金
美国国家卫生研究院;
关键词
pantothenate kinase-associated neurodegeneration (PKAN); Hallervorden-Spatz; neuropathology; tau; alpha-synuclein; HALLERVORDEN-SPATZ-SYNDROME; BRAIN IRON ACCUMULATION; NEUROAXONAL DYSTROPHY; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; IMMUNOREACTIVITY; PATHOLOGY; SYSTEM; TYPE-1; PANK2;
D O I
10.1093/brain/awr042
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pantothenate kinase-associated neurodegeneration is a form of neurodegeneration with brain iron accumulation, characterized by a progressive movement disorder and prominent iron deposition in the globus pallidus. Formerly referred to as Hallervorden-Spatz syndrome, the disorder was renamed pantothenate kinase-associated neurodegeneration after discovery of the causative gene, PANK2. Although the pathological features of clinically characterized Hallervorden-Spatz syndrome have been described, the literature is confounded by the historical use of this term for nearly all conditions with prominent basal ganglia iron accumulation and by the fact that this term encompasses a genetically heterogeneous group of disorders, now referred to as 'neurodegeneration with brain iron accumulation'. As a result, interpreting reports that precede molecular characterization of specific forms of neurodegeneration with brain iron accumulation is problematic. In the present studies, we describe neuropathological findings in six cases of molecularly confirmed pantothenate kinase-associated neurodegeneration. We identify prominent ubiquinated deposits in pantothenate kinase-associated neurodegeneration. We also characterize two distinct origins of spheroid bodies and delineate histological features of iron deposition. In so doing, we characterize fundamental features of the disease and redefine its nosological relationship to other neurodegenerative disorders.
引用
收藏
页码:947 / 958
页数:12
相关论文
共 32 条
[1]  
[Anonymous], NEUROBIOL AGING
[2]   De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system [J].
Bosveld, Floris ;
Rana, Anil ;
van der Wouden, Petra E. ;
Lemstra, Willy ;
Ritsema, Martha ;
Kampinga, Harm H. ;
Sibon, Ody C. M. .
HUMAN MOLECULAR GENETICS, 2008, 17 (13) :2058-2069
[3]   Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease [J].
Bras, Jose ;
Singleton, Andrew ;
Cookson, Mark R. ;
Hardy, John .
FEBS JOURNAL, 2008, 275 (23) :5767-5773
[4]  
DOOLING EC, 1974, ARCH NEUROL-CHICAGO, V30, P70, DOI 10.1001/archneur.1974.00490310072012
[5]   Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease [J].
Duce, James A. ;
Tsatsanis, Andrew ;
Cater, Michael A. ;
James, Simon A. ;
Robb, Elysia ;
Wikhe, Krutika ;
Leong, Su Ling ;
Perez, Keyla ;
Johanssen, Timothy ;
Greenough, Mark A. ;
Cho, Hyun-Hee ;
Galatis, Denise ;
Moir, Robert D. ;
Masters, Colin L. ;
McLean, Catriona ;
Tanzi, Rudolph E. ;
Cappai, Roberto ;
Barnham, Kevin J. ;
Ciccotosto, Giuseppe D. ;
Rogers, Jack T. ;
Bush, Ashley I. .
CELL, 2010, 142 (06) :857-867
[6]   Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome) [J].
Egan, RA ;
Weleber, RG ;
Hogarth, P ;
Gregory, A ;
Coryell, J ;
Westaway, SK ;
Gitschier, J ;
Das, S ;
Hayflick, SJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (02) :267-274
[7]   Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration [J].
Freeman, K. ;
Gregory, A. ;
Turner, A. ;
Blasco, P. ;
Hogarth, P. ;
Hayflick, S. .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2007, 51 :417-426
[8]   Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology [J].
Galvin, JE ;
Giasson, B ;
Hurtig, HI ;
Lee, VMY ;
Trojanowski, JQ .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) :361-368
[9]   Clinical and genetic delineation of neurodegeneration with brain iron accumulation [J].
Gregory, A. ;
Polster, B. J. ;
Hayflick, S. J. .
JOURNAL OF MEDICAL GENETICS, 2009, 46 (02) :73-80
[10]   The nosology of Hallervorden-Spatz disease [J].
Halliday, W .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 134 :84-91